Larson Financial Group’s AngioDynamics ANGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$308 Hold
20
– – ﹤0.01% 3660
2026
Q2
$260 Buy
20
+4
+25% +$46 ﹤0.01% 3577
2026
Q1
$182 Hold
16
– – ﹤0.01% 3464
2025
Q4
$205 Hold
16
– – ﹤0.01% 3267
2025
Q3
$179 Hold
16
– – ﹤0.01% 3272
2025
Q2
$159 Hold
16
– – ﹤0.01% 3101
2025
Q1
$150 Hold
16
– – ﹤0.01% 2846
2024
Q4
$147 Buy
+16
New +$118 ﹤0.01% 2522

Other funds holding ANGO

Larson Financial Group's ANGO Position: Q3 2026 in Review

Larson Financial Group held its AngioDynamics (ANGO) position steady in Q3 2026 at 20 shares worth $308. The position accounts for ﹤0.01% of the portfolio, ranked #3660.

Larson Financial Group first reported a position in ANGO in Q4 2024 and has held it in 8 quarters since. 116 funds tracked by Wall St. Rank hold ANGO as of Q3 2026.

  • Larson Financial Group held 20 shares of AngioDynamics worth $308 as of Q3 2026.
  • Larson Financial Group left its AngioDynamics share count unchanged in Q3 2026.
  • AngioDynamics made up ﹤0.01% of Larson Financial Group's portfolio in Q3 2026, its #3660 holding.
  • Larson Financial Group first reported a position in AngioDynamics in Q4 2024 and has held it in 8 quarters since.
  • 116 funds tracked by Wall St. Rank held AngioDynamics as of Q3 2026.

Based on Larson Financial Group's 13F filing for Q3 2026, filed 5 Nov 2026.